Setting the Course for Comprehensive Care Navigation in Oncology Evolent experts describe the key pieces of a scalable, comprehensive care navigation program in an article in Evidence-Based Oncology. Read Article
From every angle: Dr. Von Nguyen brings rare background to quest for high-value specialty care Chief Medical Officer Von Nguyen brings a background in value-based payment models, artificial intelligence and health plan operations to Evolent. Read Article
Another Toxicity of Cancer Treatment Cancer treatment and the time spent traveling for care are often very time-consuming. By recognizing and working to decrease time toxicity for patients with cancer, we can lessen their burden. Read Article
Why health plans need to refresh their surgical implant strategy Barriers related to implantable devices often keep orthopedic procedures from being peformed outside the hospital. Read Article
Evolent and Careology form strategic care navigation partnership Joint offering will seek to to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S. Read Press Release
The “dystopian” state of primary care Evolent's Dr. Kamal Golla speaks with the Healthcare Finance Management Association’s Voices podcast about the challenges of connecting primary and specialty care. Read Article
It's Cancer Prevention Month. Here are 11 ways to reduce your risk. Our CMO, Dr. Andrew Hertler, talks to Yahoo Life about identifying which patients need genetic testing or aggressive cancer screening, the issues surrounding prophylactic surgery, and more. Read External Article
Prophylactic Mastectomy for Patients With High-Risk Gene Mutations Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations. Watch Video
Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more. Read External Article
Medicare Drug Price Negotiations and Anticipated Ripple Effects Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies. Read External Article
